HISTORY OF DRUG METABOLISM RESEARCH IN JAPAN*

REFERENCES

• Tsukamoto H., Takabatake E., Yoshimura H. Metabolism of drugs. I. The metabolic fate of ethylhexabital (5-cyclohexenyl-5-ethylbarbituric acid). Pharm. Bull. 1954; 2: 201–205
   PubMedGoogle Scholar
• Yamamota A., Yoshimura H., Tsukamoto H. Metabolism of drugs. XXVIII. Metabolic fate of meprobamate. Chem. Pharm. Bull. 1962; 10: 522–528
   PubMed Web of Science ®Google Scholar
• Tsukamoto H., Yoshimura H., Tatsumi K. Metabolism of drugs. XXXIX. Further studies on carbamate N-glucuronide formation in animal body. Chem. Pharm. Bull. 1963; 11: 1134–1139
   PubMed Web of Science ®Google Scholar
• Uno T., Ueda M. Studies on the metabolism of sulfathiazole. IV. A new sulfathiazole glucuronic acid conjugate in the human urine. Chem. Pharm. Bull. 1963; 11: 709–712
   PubMed Web of Science ®Google Scholar
• Akaghi M., Uematsu T., Aoki I., Sakata M. Structure of p-ethoxyphenylurea-N-glucuronide. Chem. Pharm. Bull. 1963; 11: 1214–1215
   PubMed Web of Science ®Google Scholar
• Kato R. A treatment, carried out 48 hr before, with various substances can decrease the pharmacological effect of phenobarbital. Atti. Soc. Lombarda Sci. Med. Biol. 1959; 14: 777–780, (in Italian)
   Google Scholar
• Kato R. Modification of pharmacological action of some drugs in animals pretreated 48 hr before, with other drugs. Atti. Soc. Lombarda Sci. Med. Biol. 1959; 14: 783–786, (in Italian)
   Google Scholar
• Kato R. Some characteristics of decrease in sensitivity to phenobarbital in animals pretreated with phenaglycodol. Atti. Soc. Lombarda Sci. Med. Biol. 1959; 14: 781–783, (in Italian)
   Google Scholar
• Kato R. Induced increase of meprobamate metabolism in rats treated with phenobarbital or phenaglycodol. Med. Exp. 1960; 3: 95–100
   Google Scholar
• Kato R. Modifications of the toxicity of strychnine and octomethylpyrophosphoramide (OMPA) induced by pretreatment with phenaglycodol and thiopental. Arzneim. Forsch. 1961; 11: 797–798
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E. Increase of pentobarbitone metabolism induced in rats pretreated with some centrally acting compounds. Br. J. Pharmacol. 1962; 18: 29–38
   Web of Science ®Google Scholar
• Kato R., Chiesara E., Vassanelli P. Factors influencing induction of hepatic microsomal drug-metabolizing enzymes. Biochem. Pharmacol. 1962; 11: 211–220
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E., Vassanelli P. Increased activity of microsomal strychnine-metabolizing enzyme induced by phenobarbital and other drugs. Biochem. Pharmacol. 1962; 11: 913–922
   PubMed Web of Science ®Google Scholar
• Kato R., Vassanelli P., Chiesara E. Inhibition of pentobarbital and meprobamate metabolism by some inducers of drug-metabolizing enzymes. Experientia 1962; 18: 453–456
   PubMedGoogle Scholar
• Kato R., Chisara E., Vassanelli P. Stimulating effect of some inhibitors of the drug metabolisms (SKF 525 A, Lilly 18947, Lilly 32391 and MG 3062) on excretion of ascorbic acid and drug metabolisms. Med. Exp. 1962; 6: 254–260
   PubMedGoogle Scholar
• Kato R., Chiesara E., Vassanelli P. Mechanism of potentiation of barbiturates and meprobamate actions by imipramine. Biochem. Pharmacol. 1963; 12: 357–364
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E., Vassanelli P. Further studies on the inhibition and stimulation of microsomal drug-metabolizing enzymes of rat liver by various compounds. Biochem. Pharmacol. 1964; 13: 69–83
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E., Frontino G. Influence of sex difference on the pharmacological action and metabolism of some drugs. Biochem. Pharmacol. 1962; 11: 221–227
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E., Vassanelli P. Metabolic differences of strychnine in the rat in relation to sex. Jpn. J. Pharmacol. 1962; 12: 26–33
   PubMedGoogle Scholar
• Kato R., Vassanelli P., Frontino G., Chiesara E. Variation in the activity of liver microsomal drug-metabolizing enzymes in rats in relation to the age. Biochem. Pharmacol. 1964; 13: 1037–1051
   PubMed Web of Science ®Google Scholar
• Kato R., Chiesara E., Frontino G. Induced increase of meprobamate metabolism in rats pretreated with phenobarbital or phenaglycodol in relation to age. Experientia 1961; 17: 520–523
   PubMedGoogle Scholar
• Kato R., Takanaka A. Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats. Jpn. J. Pharmacol. 1968; 18: 381–388
   PubMedGoogle Scholar
• Kato R., Takanaka A. Effect of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different age. J. Biochem. 1968; 63: 406–408
   PubMed Web of Science ®Google Scholar
• Kato R., Vassanelli P., Frontino G. Metabolic factors determining a higher resistance to strychnine in guinea pigs. Arch. Int. Pharmacodyn. 1963; 144: 416–422
   PubMedGoogle Scholar
• Kato R., Chiesara E., Vassanelli P. Metabolic differences of carisoprodol in the rat in relation to sex. Med. Exp. 1961; 4: 387–392
   PubMedGoogle Scholar
• Kato R., Gillette J. R. Effect of starvation on NADPH-dependent enzymes in liver microsomes of male and female rats. J. Pharmacol. Exp. Ther. 1965; 150: 279–284
   Web of Science ®Google Scholar
• Kato R., Gillette J. R. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J. Pharmacol. Exp. Ther. 1965; 150: 285–291
   PubMed Web of Science ®Google Scholar
• Kato R. This week's citation classic. Current Content 1984; 46: 16
   Google Scholar
• Kato R. Hepatic microsomal drug-metabolizing enzyme-determinant of efficacy and toxicity of drugs. Farumashia 1965; 1: 161
   Google Scholar
• Kato R., Loeb L., Gelboin H. V. Increased sensitivity of microsomes from phenobarbital-treated rats to synthetic messenger RNA (polyuridylic acid): Lack of effect on ribosomes. Nature 1965; 205: 668–669
   PubMed Web of Science ®Google Scholar
• Kato R., Jondorf W. R., Loeb L. A., Ben T., Gelboin H. V. Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol. Pharmacol. 1966; 2: 171–186
   PubMed Web of Science ®Google Scholar
• Kato R. Possible role of P-450 in the oxidation of drugs in liver microsomes. J. Biochem. 1966; 59: 574–583
   PubMed Web of Science ®Google Scholar
• Kato R., Takahashi A. Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes. Mol. Pharmacol. 1968; 4: 109–120
   PubMed Web of Science ®Google Scholar
• Kato R., Takanaka A., Onoda K. Substrate interaction with P-450 and drug hydroxylation by liver microsomes of rats under physiologically abnormal states. J. Biochem. 1969; 66: 739–741
   PubMed Web of Science ®Google Scholar
• Kato R., Onoda K., Sasajima M. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes. Jpn. J. Pharmacol. 1970; 20: 194–209
   PubMedGoogle Scholar
• Kato R., Onoda K., Takayanagi M. Species and sex differences in the substrate-induced spectral change of P-450 in relation to the activity of drug oxidation in liver microsomes. Jpn. J. Pharmacol. 1970; 20: 157–163
   PubMedGoogle Scholar
• Kato R., Takanaka A., Onoda K. Species and sex differences in aminopyrine N-demethylating activity of liver microsomes under unphysiological conditions. Jpn. J. Pharmacol. 1968; 18: 516–517
   PubMedGoogle Scholar
• Kato R., Onoda K. I., Takanaka A. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes. Biochem. Pharmacol. 1971; 20: 1093–1099
   PubMed Web of Science ®Google Scholar
• Kato R. Sex-related differences in drug metabolism. Drug Metab. Rev. 1974; 3: 1–32
   PubMed Web of Science ®Google Scholar
• Kato R., Takahashi A., Oshima T., Hosoya E. Effect of morphine administration on the hydroxylation of steroid hormones by rat liver microsomes. J. Pharmacol. Exp. Ther. 1970; 174: 211–220
   PubMed Web of Science ®Google Scholar
• Kato R., Takahashi A., Omori Y. Effects of thyroxine and thyroidectomy on the hydroxylation of testosterone by liver microsomes from male and female rats. Biochem. Biophys. Acta 1970; 208: 116–124
   PubMed Web of Science ®Google Scholar
• Kato R., Takahashi A. Decreased hydroxylation of steroid hormones by liver microsomes from rats bearing Walker carcinosarcoma 256. Cancer Res. 1970; 30: 2346–2352
   PubMed Web of Science ®Google Scholar
• Kato R., Oshima T., Tomizawa S. Toxicity and metabolism of drugs in relation to dietary protein. Jpn. J. Pharmacol. 1968; 18: 356–366
   PubMedGoogle Scholar
• Kato R. Diet, drugs and poisons. Current Content 1991; 34: 10
   Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Nagai T., Kato R. Partial purification and characterization of cytochrome P-450 responsible for the occurrence of sex difference in drug metabolism in the rat. Biochem. Biophys. Res. Commun. 1981; 103: 1–7
   PubMed Web of Science ®Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Nagai T., Kato R. Sex difference of cytochrome P-450 in the rat: Purification, characterization, and quantitation of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. Arch. Biochem. Biophys. 1983; 225: 758–770
   PubMed Web of Science ®Google Scholar
• Kamataki T., Shimada M., Maeda K., Kato R. Pituitary regulation of sex-specific forms of cytochrome P-450 in liver microsomes of rats. Biochem. Biophys. Res. Commun. 1985; 130: 1247–1253
   PubMed Web of Science ®Google Scholar
• Kamataki T., Maeda K., Shimada M., Nagai T., Kato R. Neonatal testosterone imprinting of hepatic microsomal drug metabolism and a male-specific form of cytochrome P-450 in the rat. J. Biochem. 1984; 96: 1939–1942
   PubMed Web of Science ®Google Scholar
• Kamataki T., Maeda K., Shimada M., Kitani K., Nagai T., Kato R. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sexspecific forms of cytochrome P-450 in liver microsomes from male and female rats. J. Pharmacol. Exp. Ther. 1985; 233: 222–228
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Shimada M., Kamataki T., Kato R. Effects of hypophysectomy and growth hormone treatment on sex-specific forms of cytochrome P-450 in relation to drug and steroid metabolisms in rat liver microsomes. Jpn. J Pharmacol. 1986; 42: 371–382
   PubMedGoogle Scholar
• Yamazoe Y., Shimada M., Murayama N., Kawano S., Kato R. The regulation by growth hormone of microsomal testosterone 6β-hydroxylase in male rat livers. J. Biochem. 1986; 100: 1095–1097
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Hormonal regulation of sex-specific forms of cytochrome P-450 involved in hydroxylation of steroid and drugs. Microsomes and Drug Oxidations, J. Miners, D. J. Birkett, R. Drew, M. L. McManus. Taylor & Francis, London 1988; 140–147
   Google Scholar
• Kato R., Yamazoe Y. Hormonal regulation of cytochrome P450 in rat liver. Handbook of Experimental Pharmacology, Vol. 105 Cytochrome P450, J. B. Schenkman, H. Greim. Springer-Verlag, Berlin 1993; 447–450
   Google Scholar
• Yamazoe Y., Murayama N., Shimada M., Yamauchi K., Kato R. Cytochrome P450 in livers of diabetic rats: Regulation by growth hormone and insulin. Arch. Biochem. Biophys. 1989; 268: 567–575
   PubMed Web of Science ®Google Scholar
• Shimada M., Murayama N., Yamazoe Y., Hashimoto H., Ishikawa H., Kato R. Age- and sex-related alterations of microsomal drug- and testosterone-oxidizing cytochrome P450 in Sprague Dawley strain-derived dwarf rats. J. Pharmacol. Exp. Ther. 1995; 275: 972–977
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Manabe S., Murayama N., Kato R. Regulation of hepatic sulfotransferase catalyzing the activation of N-hydroxyarylamide and N-hydroxyarylamine by growth hormone. Mol. Pharmacol. 1987; 32: 536–541
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Gong D., Murayama N., Abu-Zeid M., Kato R. Regulation of hepatic cortisol sulfotransferase in rats by pituitary growth hormone. Mol. Pharmacol. 1989; 35: 707–712
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Shimada M., Murayama N., Kato R. Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J. Biol. Chem. 1987; 262: 7423–7428
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Ishii K., Kamataki T., Kato R., Sugimura T. Isolation and characterization of active metabolites of tryptophan pyrolysate mutagen. TRP-P-2, formed by rat liver microsomes. Chem. Biol. Interact. 1980; 30: 125–138
   PubMed Web of Science ®Google Scholar
• Mita S., Ishii K., Yamazoe Y., Kamataki T., Kato R., Sugimura T. Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA. Cancer Res. 1981; 41: 3610–3614
   PubMed Web of Science ®Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Matsuda N., Ishii K., Kato R. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes. Mol. Pharmacol. 1983; 24: 146–155
   PubMed Web of Science ®Google Scholar
• Ishii K., Ando M., Kamataki T., Kato R., Nagao M. Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system. Cancer Lett. 1980; 9: 271–276
   PubMed Web of Science ®Google Scholar
• Ishii K., Yamazoe Y., Kamataki T., Kato R. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole and 2-amino-dipyrido[1,2-a:3′,2′-d]imidazole, by purified cytochrome P-450. Chem. Biol. Interact 1981; 38: 1–13
   PubMed Web of Science ®Google Scholar
• Saito K., Yamazoe Y., Kamataki T., Kato R. Mechanism of activation of proximate mutagens in Ames' tester strains: The acetyl-CoA dependent enzyme in Salmonella typhimurium TA98 deficient in TA98/1,8-DNP6 catalyzes DNA-binding as the cause of mutagenicity. Biochem. Biophys. Res. Commun. 1983; 116: 141–147
   PubMed Web of Science ®Google Scholar
• Saito K., Yamazoe Y., Kamataki T., Kato R. Syntheses of hydroxyamino, nitroso and nitro derivatives of Trp-P-2 and Glu-P-1, amino acid pyrolysate mutagens, and their direct mutagenicities towards Salmonella typhimurium TA98 and TA98NR. Carcinogenesis 1983; 4: 1547–1550
   PubMed Web of Science ®Google Scholar
• Saito K., Shinohara A., Kamataki T., Kato R. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys. 1985; 239: 286–295
   PubMed Web of Science ®Google Scholar
• Saito K., Shinohara A., Kamataki T., Kato R. N-Hydroxyarylamine O-acetyltransferase in hamster liver: Identity with arylhydroxamic acid N, O-acetyltransferase and arylamine N-acetyltransferase. J. Biochem. 1986; 99: 1689–1697
   PubMed Web of Science ®Google Scholar
• Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. DNA binding of N-hydroxy-Trp-P-2 and N-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mammalian liver cytosol. Carcinogenesis 1985; 6: 305–307
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Shimada M., Shinohara A., Saito K., Kamataki T., Kato R. Catalysis of the covalent binding of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol. Cancer Res. 1985; 45: 2495–2500
   PubMed Web of Science ®Google Scholar
• Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: Mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Cancer Res. 1986; 46: 4362–4367
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn. J. Cancer Res. 1987; 78: 297–311
   PubMedGoogle Scholar
• Abu-Zeid M., Yamazoe Y., Kato R. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals. Carcinogenesis 1992; 13: 1307–1314
   PubMed Web of Science ®Google Scholar
• Nagata K., Ozawa S., Miyata M., Shimada M., Gong D. W., Yamazoe Y., Kato R. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 1993; 268: 24,720–24,725
   Google Scholar
• Yamazoe Y., Abu-Zeid M., Gong D. W., Staiano N., Kato R. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers. Carcinogenesis 1989; 10: 1675–1679
   PubMed Web of Science ®Google Scholar
• Kawakubo Y., Manabe S., Yamazoe Y., Nishikawa T., Kato R. Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine. Biochem. Pharmacol. 1988; 37: 265–270
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. N-Hydroxyarylamine O-acetyltransferase in mammalian livers and salmonella. Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, C. M. King, L. J. Romano, D. Schuetzle. Elsevier Science, New York 1988; 125–136
   Google Scholar
• Ozawa S., Abu-Zeid M., Kawakubo Y., Toyama S., Yamazoe Y., Kato R. Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: Purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis 1990; 11: 2137–2144
   PubMed Web of Science ®Google Scholar
• Abu-Zeid M., Nagata K., Miyata M., Ozawa S., Fukuhara M., Yamazoe Y., Kato R. An arylamine acetyltransferase (AT-I) from Syrian golden hamster liver: Cloning, complete nucleotide sequence, and expression in mammalian cells. Mol. Carcinogen. 1991; 4: 81–88
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Molecular mechanisms of polymorphism in acetylating enzymes for arylamines and N-hydroxyarylamines in hamster liver. Drug Metab. Rev. 1995; 27: 241–256
   PubMed Web of Science ®Google Scholar
• Nagata K., Ozawa S., Miyata M., Shimada M., Yamazoe Y., Kato R. Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II)/in hamsters. Pharmacogenetics 1994; 4: 91–100
   PubMedGoogle Scholar
• Ando M., Shindo Y., Fujita M., Ozawa S., Yamazoe Y., Kato R. A new Salmonella tester strain expressing a hamster acetyltransferase shows high sensitivity for arylamines. Mutat. Res. 1993; 292: 155–163
   PubMed Web of Science ®Google Scholar
• Ozawa S., Nagata K., Gong D. W., Yamazoe Y., Kato R. Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulfotransferase from rat liver. Nucl. Acids Res. 1990; 18: 4001
   PubMed Web of Science ®Google Scholar
• Ozawa S., Nagata K., Gong D. W., Yamazoe Y., Kato R. Expression and functional characterization of a rat sulfotransferase (ST1A1) cDNA for sulfations of phenolic substrates in COS-1 cells. Jpn. J. Pharmacol. 1993; 61: 153–156
   PubMedGoogle Scholar
• Ozawa S., Chou H. C., Kadlubar F. F., Nagata K., Yamazoe Y., Kato R. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn. J. Cancer Res. 1994; 85: 1220–1228
   PubMedGoogle Scholar
• Ozawa S., Nagata K., Yamazoe Y., Kato R. Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases. Jpn. J. Cancer Res. 1995; 86: 264–269
   PubMedGoogle Scholar
• Yamazoe Y., Nagata K., Ozawa S., Kato R. Structural similarity and diversity of sulfotransferases. Chem Biol. Interact. 1994; 92: 107–117
   PubMed Web of Science ®Google Scholar
• Kamataki T., Sugiura Y., Yamazoe Y., Kato R. Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes. Biochem. Pharmacol. 1979; 28: 1993–2000
   PubMed Web of Science ®Google Scholar
• Kawano S., Kamataki T., Yasumori T., Yamazoe Y., Kato R. Purification of human liver cytochrome P-450 catalyzing testosterone 6β-hydroxylation. J. Biochem. 1987; 102: 493–501
   PubMed Web of Science ®Google Scholar
• Yasumori T., Kawano S., Nagata K., Shimada M., Yamazoe Y., Kato R. Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J. Biochem. 1987; 102: 1075–1082
   PubMed Web of Science ®Google Scholar
• Yasumori T., Murayama N., Yamazoe Y., Abe A., Nogi Y., Fukasawa T., Kato R. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol. Pharmacol. 1989; 35: 443–449
   PubMed Web of Science ®Google Scholar
• Yasumori T., Murayama N., Yamazoe Y., Kato R. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clin. Pharmacol. Ther. 1990; 47: 313–322
   PubMed Web of Science ®Google Scholar
• Yasumori T., Li Q. H., Yamazoe Y., Ueda M., Tsuzuki T., Kato R. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4′-hydroxylation. Pharmacogenetics 1994; 4: 323–331
   PubMedGoogle Scholar
• Kato R., Yamazoe Y. The importance of substrate concentration in determining cytochromes P450 therapeutically relevant in vivo. Pharmacogenetics 1994; 4: 359–362
   PubMedGoogle Scholar
• Miyata M., Nagata K., Shimada M., Yamazoe Y., Kato R. Structure of a gene and cDNA of a major constitutive form of testosterone 6β-hydroxylase (P450/6βA) encoding CYP3A2: Comparison of the cDNA with P450PCN2. Arch. Biochem. Biophys. 1994; 314: 351–359
   PubMed Web of Science ®Google Scholar
• Miyata M., Nagata K., Yamazoe Y., Kato R. Transcriptional elements directing a liver-specific expression of P450/6βA(CYP3A2) gene-encoding testosterone 6β-hydroxylase. Arch. Biochem. Biophys. 1995; 318: 71–79
   PubMed Web of Science ®Google Scholar
• Murayama N., Shimada M., Yamazoe Y., Sogawa K., Nakayama K., Fujii-Kuriyama Y., Kato R. Distinct effects of phenobarbital and its N-methylated derivative on liver cytochrome P450 induction. Arch. Biochem. Biophys. 1996; 328: 184–192
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization purification, and properties. J. Biol. Chem. 1964; 239: 2379–2385
   PubMed Web of Science ®Google Scholar
• Imai Y., Sato R. Studies on the substrate interactions with P-450 in drug hydroxylation by liver microsomes. J. Biochem. 1967; 62: 239–249
   PubMed Web of Science ®Google Scholar
• Imai Y., Sato R. A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits. Biochem. Biophys. Res. Commun. 1974; 60: 8–14
   PubMed Web of Science ®Google Scholar
• Imai Y. The roles of cytochrome b5 in reconstituted monooxygenase systems containing various forms of hepatic microsomal cytochrome P-450. J. Biochem. 1981; 89: 351–362
   PubMed Web of Science ®Google Scholar
• Imai Y. Cytochrome P-450 related to P-4504 from phenobarbital-treated rabbit liver: Molecular cloning of cDNA and characterization of cytochrome P-450 obtained by its expression in yeast cells. J. Biochem. 1987; 101: 1129–1139
   PubMed Web of Science ®Google Scholar
• Ohta D., Matsu-ura Y., Sato R. Expression and characterization of a rabbit liver cytochrome P450 belonging to P450IIB subfamily with the aid of the baculovirus expression vector system. Biochem. Biophys. Res. Commun. 1991; 175: 394–399
   PubMed Web of Science ®Google Scholar
• Uno T., Imai Y. Further studies on chimeric P450 2C2/2C14 having testosterone 16β-hydroxylase activity which is absent in the parental P450s. J. Biochem. 1992; 112: 155–162
   PubMed Web of Science ®Google Scholar
• Kuriyama Y., Omura T. Different turnover behavior of phenobarbital-induced and normal NADPH–cytochrome c reductases in rat liver microsomes. J. Biochem. 1971; 69: 659–669
   PubMed Web of Science ®Google Scholar
• Harada N., Omura T. Selective induction of two different molecular species of cytochrome P-450 by phenobarbital and 3-methylchoranthrene. J. Biochem. 1981; 89: 237–248
   PubMed Web of Science ®Google Scholar
• Kuwahara S., Harada N., Yoshioka H., Miyta T., Omura T. Purification and characterization of four forms of cytochrome P-450 from liver microsomes of phenobarbital-treated and 3-methylcholanthrene-treated rats. J. Biochem. 1984; 95: 703–714
   PubMed Web of Science ®Google Scholar
• Morohashi K., Yoshioka H., Sogawa K., Fujii-Kuriyama Y., Omura T. Induction of mRNA coding for phenobarbital-inducible form of microsomal cytochrome P-450 in rat liver by administration of 1,1-di(p-chlorophenyl)-2,2-dichloroethylene and phenobarbital. J. Biochem. 1984; 95: 949–957
   PubMed Web of Science ®Google Scholar
• Matsumoto T., Emi Y., Kawabata S., Omura T. Purification and characterization of three male-specific and one female-specific forms of cytochrome P-450 from rat liver microsomes. J. Biochem. 1986; 100: 1359–1371
   PubMed Web of Science ®Google Scholar
• Yoshioka H., Morohashi K., Sogawa K., Miyata T., Kawajiri K., Hirose T., Inayama S., Fujii-Kuriyama Y., Omura T. Structural analysis and specific expression of microsomal cytochrome P-450(M-1) mRNA in male rat livers. J. Biol. Chem. 1987; 262: 1706–1711
   PubMed Web of Science ®Google Scholar
• Mannering G. J., Kuwahara S., Omura T. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent monooxidase system of hepatic microsomes. Biochem. Biophys. Res. Commun. 1974; 57: 476–481
   PubMed Web of Science ®Google Scholar
• Kuwahara S., Omura T. Different requirement for cytochrome b5 in NADPH-supported O-deethylation of p-nitrophenetole catalyzed by two types of microsomal cytochrome P450. Biochem. Biophys. Res. Commun. 1980; 96: 1562–1568
   PubMed Web of Science ®Google Scholar
• Kamataki T., Kitagawa H. Effects of lipid peroxidation on activities of drug-metabolizing enzymes in liver microsomes of rats. Biochem. Pharmacol. 1973; 22: 3199–3207
   PubMed Web of Science ®Google Scholar
• Kuo C. K., Hanioka N., Hoshikawa Y., Oguri K., Yoshimura H. Species difference of site-selective glucuronidation of morphine. J. Pharmacobiodyn. 1991; 14: 187–193
   PubMedGoogle Scholar
• Osborne R., Joel S., Trew D., Slevin M. Analgesic activity of morphine-6-glucuronide. Lancet 1988; 1: 828
   PubMed Web of Science ®Google Scholar
• Ishii Y., Oguri K., Yoshimura H. Purification and characterization of a morphine UDP-glucuronyltransferase isoform from untreated rat liver. Biol. Pharm. Bull. 1993; 16: 754–758
   PubMed Web of Science ®Google Scholar
• Yamada H., Yuno K., Oguri K., Yoshimura H. Multiplicity of liver microsomal flavin-containing monooxygenase in the guinea pig: Its purification and characterization. Arch. Biochem. Biophys. 1990; 280: 305–312
   PubMed Web of Science ®Google Scholar
• Yamada H., Honda S., Oguri K., Yoshimura H. A rabbit liver constitutive form of cytochrome P450 responsible for amphetamine deamination. Arch. Biochem. Biophys. 1989; 273: 26–33
   PubMed Web of Science ®Google Scholar
• Yoshimura H., Yoshihara S., Ozawa N., Miki M. Possible correlation between induction modes of hepatic enzymes by PCBs and their toxicity in rats. Ann. NY Acad. Sci. 1979; 320: 179–192
   PubMedGoogle Scholar
• Ariyoshi N., Oguri K., Koga N., Yoshimura H., Funae Y. Metabolism of highly persistent PCB congener, 2,4,5,2′,4′,5′-hexachlorobiphenyl, by human CYP2B6. Biochem. Biophys. Res. Commun. 1995; 212: 455–460
   PubMed Web of Science ®Google Scholar
• Fujisaki H., Mise M., Ishii Y., Yamada H., Oguri K. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: Different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase. J. Pharmacol. Exp. Ther. 1994; 268: 1024–1031
   PubMed Web of Science ®Google Scholar
• Yamada H., Minematsu Y., Nakamura T., Mise M., Fujisaki H., Oguri K. Brucine as a potent inducer of CYP2B3, the third member of the CYP2B subfamily P450 in rats. Biol. Pharm. Bull. 1996; 19: 291–293
   PubMed Web of Science ®Google Scholar
• Fujii-Kuriyama Y., Mizukami Y., Kawajiri K., Sogawa K., Muramatsu M. Primary structure of a cytochrome P-450: Coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. Proc. Natl. Acad. Sci. USA 1982; 79: 2793–2797
   PubMed Web of Science ®Google Scholar
• Kawajiri K., Gotoh O., Sogawa K., Tagashira Y., Muramatsu M., Fujii-Kuriyama Y. Coding nucleotide sequence of 3-methylcholanthrene-inducible cytochrome P-450d cDNA from rat liver. Proc. Natl. Acad. Sci. USA 1984; 81: 1649–1653
   PubMed Web of Science ®Google Scholar
• Gotoh O., Fujii-Kuriyama Y. Evolution, structure, and gene regulation of cytochrome P-450. Frontiers in Biotransformation, K. Ruckpaul. Akademie-Verlag, Berlin 1989; 195–243
   Google Scholar
• Morohashi K., Fujii-Kuriyama Y., Okada Y., Sogawa K., Hirose T., Inayama S., Omura T. Molecular cloning and nucleotide sequence of cDNA for mRNA of mitochondrial cytochrome P-450(SCC) of bovine adrenal cortex. Proc. Natl. Acad. Sci. USA 1984; 81: 4647–4651
   PubMed Web of Science ®Google Scholar
• Morohashi K., Yoshioka H., Gotoh O., Okada Y., Yamamoto K., Miyata T., Sogawa K., Fujii-Kuriyama Y., Omura T. Molecular cloning and nucleotide sequence of DNA of mitochondrial cytochrome P-450(11 beta) of bovine adrenal cortex. J. Biochem. 1987; 102: 559–568
   PubMed Web of Science ®Google Scholar
• Lorence M. C., Trant J. M., Mason J. I., Bhasker C. R., Fujii-Kuriyama Y., Estabrook R. W., Waterman M. R. Expression of a full-length cDNA encoding bovine adrenal cytochrome P450C21. Arch. Biochem. Biophys. 1989; 273: 79–88
   PubMed Web of Science ®Google Scholar
• Gotoh O., Tagashira Y., Iizuka T., Fujii-Kuriyama Y. Structural characteristics of cytochrome P-450 Possible location of the heme-binding cysteine in determined amino-acid sequences. J. Biochem. 1983; 93: 807–817
   PubMed Web of Science ®Google Scholar
• Sogawa K., Gotoh O., Kawajiri K., Fujii-Kuriyama Y. Distinct organization of methylcholanthrene- and phenobarbital-inducible cytochrome P-450 genes in the rat. Proc. Natl. Acad. Sci. USA 1984; 81: 5066–5070
   PubMed Web of Science ®Google Scholar
• Fujisawa-Sehara A., Yamane M., Fujii-Kuriyama Y. A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: Its possible translocation to nucleus. Proc. Natl. Acad. Sci. USA 1988; 85: 5859–5863
   PubMed Web of Science ®Google Scholar
• Yanagida A., Sogawa K., Yasumoto K. I., Fujii-Kuriyama Y. A novel cis-acting DNA element required for a high level of inducible expression of the rat P-450c gene. Mol. Cell. Biol. 1990; 10: 1470–1475
   PubMed Web of Science ®Google Scholar
• Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., Funae Y., Fujii-Kuriyama Y. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 1992; 184: 246–253
   PubMed Web of Science ®Google Scholar
• Imataka H., Sogawa K., Yasumoto K., Kikuchi Y., Sasano K., Kobayashi A., Hayami M., Fujii-Kuriyama Y. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 1992; 11: 3663–3671
   PubMed Web of Science ®Google Scholar
• Matsushita N., Sogawa K., Ema M., Yoshida A., Fujii-Kuriyama Y. A factor binding to the xenobiotic responsive element (XRE) of P-4501A1 gene consists of at least two helix–loop–helix proteins. Ah receptor and Arnt. J. Biol. Chem. 1993; 268: 21,002–21,006
   Google Scholar
• Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Brooks B. A., Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991; 252: 954–958
   PubMed Web of Science ®Google Scholar
• Ema M., Ohe N., Suzuki M., Mimura J., Sogawa K., Ikawa S., Fujii-Kuriyama Y. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem. 1994; 269: 27,337–27,343
   Google Scholar
• Tatsumi K., Kitamura S., Yamada H. Sulfoxide reductase activity of liver aldehyde oxidase. Biochim. Biophys. Acta 1983; 747: 86–92
   PubMed Web of Science ®Google Scholar
• Kitamura S., Wada Y., Tatsumi K. NAD(P)H-dependent reduction of nicotinamide N-oxide by an unique enzyme system consisting of liver microsomal NADPH-cytochrome c reductase and cytosolic aldehyde oxidase. Biochem. Biophys. Res. Commun. 1984; 125: 1117–1122
   PubMed Web of Science ®Google Scholar
• Tatsumi K., Ishigai M. Oxime-metabolizing activity of liver aldehyde oxidase. Arch. Biochem. Biophys. 1987; 253: 413–418
   PubMed Web of Science ®Google Scholar
• Hirao Y., Kitamura S., Tatsumi K. Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase. Carcinogenesis 1994; 15: 739–743
   PubMed Web of Science ®Google Scholar
• Kitamura S., Sugihara K., Tatsumi K. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Biochem. Mol. Biol. Int. 1994; 34: 1197–1203
   PubMedGoogle Scholar
• Kitamura S., Tatsumi K. Purification of NADPH-linked alpha, beta-ketoalkene double bond reductase from rat liver. Arch. Biochem. Biophys. 1990; 282: 183–187
   PubMed Web of Science ®Google Scholar
• Maynert E. W., Foreman R. L., Watabe T. Epoxides as obligatory intermediates in the metabolism of olefins to glycols. J. Biol. Chem. 1970; 245: 5234–5238
   PubMed Web of Science ®Google Scholar
• Oesch F. Mammalian epoxide hydrases: Inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 1973; 3: 305–340
   PubMed Web of Science ®Google Scholar
• Watabe T., Komatsu T., Kobayashi K., Isobe M., Ozawa N., Saitoh Y. The obligatory intermediacy of 16,17 alpha- and 16,17 beta-epoxides in the biotransformation of androsta-5,16-dien-3 beta-ol to androst-5-ene-3 beta, 16 alpha, 17 beta- and -3 beta, 16 beta, 17 alpha-triols by male rat liver microsomes. J. Biol. Chem. 1985; 260: 8716–8720
   PubMed Web of Science ®Google Scholar
• Ogura K., Sohtome T., Sugiyama A., Okuda H., Hiratsuka A., Watabe T. Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes. Mol. Pharmacol. 1990; 37: 848–854
   PubMed Web of Science ®Google Scholar
• Ogura K., Kajita J., Narihata H., Watabe T., Ozawa S., Nagata K., Yamazoe Y., Kato R. cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP2 in rat livers. Biochem. Biophys. Res. Commun. 1990; 166: 1494–1500
   PubMed Web of Science ®Google Scholar
• Watabe T., Ogura K., Satsukawa M., Okuda H., Hiratsuka A. Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem. Biol. Int. 1994; 92: 87–105
   PubMed Web of Science ®Google Scholar
• Hiratsuka A., Sebata N., Kawashima K., Okuda H., Ogura K., Watabe T., Satoh K., Hatayama I., Tsuchida S., Ishikawa T. A new class of rat glutathione S-transferase Yrs-Yrs inactivating reactive sulfate esters as metabolites of carcinogenic arylmethanols. J. Biol. Chem. 1990; 265: 11,973–11,981
   Google Scholar
• Ogura K., Nishiyama T., Hiratsuka A., Watabe T., Watabe T. Isolation and characterization of the gene encoding rat class theta glutathione S-transferase subunit yrs. Biochem. Biophys. Res. Commun. 1994; 205: 1250–1256
   PubMed Web of Science ®Google Scholar
• Kamataki T., Neal R. A. Metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) by a reconstituted mixed-function oxidase enzyme system: Studies of the covalent binding of the sulfur atom. Mol. Pharmacol. 1976; 12: 933–944
   PubMed Web of Science ®Google Scholar
• Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kanakubo Y. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem. 1987; 262: 13,534–13,537
   Google Scholar
• Komori M., Nishio K., Ohi H., Kitada M., Kamataki T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J. Biochem. 1989; 105: 161–163
   PubMed Web of Science ®Google Scholar
• Komori M., Nishio K., Kitada M., Shiramatsu K., Muroya K., Soma M., Nagashima K., Kamataki T. Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 1990; 29: 4430–4433
   PubMed Web of Science ®Google Scholar
• Kitamura R., Sato K., Sawada M., Itoh S., Kitada M., Komori M., Kamataki T. Stable expression of cytochrome P450IIIA7 cDNA in human breast cancer cell line MCF-7 and its application to cytotoxicity testing. Arch. Biochem. Biophys. 1992; 292: 136–140
   PubMed Web of Science ®Google Scholar
• Hashimoto H., Nakagawa T., Yokoi T., Sawada M., Itoh S., Kamataki T. Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in Chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins. Cancer Res. 1995; 55: 787–791
   PubMed Web of Science ®Google Scholar
• Kitada M., Kato T., Ohmori S., Kamataki T., Itahashi K., Guengerich F. P., Rikihisa T., Kanakubo Y. Immunochemical characterization and toxicological significance of P-450HFLb purified from human fetal livers. Biochim. Biophys. Acta 1992; 1117: 301–305
   PubMed Web of Science ®Google Scholar
• Hashimoto H., Yanagawa Y., Sawada M., Itoh S., Deguchi T., Kamataki T. Simultaneous expression of human CYP3A7 and N-acetyltransferase in Chinese hamster CHL cells results in high cytotoxicity for carcinogenic heterocyclic amines. Arch. Biochem. Biophys. 1995; 320: 323–329
   PubMed Web of Science ®Google Scholar
• Li Y., Yokoi T., Kitamura R., Sasaki M., Gunji M., Katsuki M., Kamataki T. Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch. Biochem. Biophys. 1996; 329: 235–240
   PubMed Web of Science ®Google Scholar
• Itoh S., Yanagimoto T., Tagawa S., Hashimoto H., Kitamura R., Nakajima Y., Okochi T., Fujimoto S., Uchino J., Kamataki T. Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in the 5′ flanking region. Biochim. Biophys. Acta 1992; 1130: 133–138
   PubMed Web of Science ®Google Scholar
• Hashimoto H., Toide K., Kitamura R., Fujita M., Tagawa S., Itoh S., Kamataki T. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur. J. Biochem. 1993; 218: 585–595
   PubMedGoogle Scholar
• Yanagawa Y., Sawada M., Deguchi T., Gonzalez F. J., Kamataki T. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res. 1994; 54: 3422–3427
   PubMed Web of Science ®Google Scholar
• Nakajima M., Yokoi T., Mizutani M., Shin S., Kadlubar F. F., Kamataki T. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: Absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol. Biomark. Prevent. 1994; 3: 413–421
   PubMed Web of Science ®Google Scholar
• Itoh S., Satoh M., Abe Y., Hashimoto H., Yanagimoto T., Kamataki T. A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver. Eur. J. Biochem. 1994; 226: 877–882
   PubMedGoogle Scholar
• Sakuma T., Masaki K., Itoh S., Yokoi T., Kamataki T. Sex-related difference in the expression of cytochrome P450 in hamsters: cDNA cloning and examination for the expression of three distinct CYP2C cDNAs. Mol. Pharmacol. 1993; 45: 228–236
   Web of Science ®Google Scholar
• Uchida T., Komori M., Kitada M., Kamataki T. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs. Mol. Pharmacol. 1990; 38: 644–651
   PubMed Web of Science ®Google Scholar
• Komori M., Kikuchi O., Kitada M., Kamataki T. Molecular cloning of monkey P450 1A1 cDNA and expression in yeast. Biochim. Biophys. Acta 1992; 1131: 23–29
   PubMed Web of Science ®Google Scholar
• Komori M., Kikuchi O., Sakuma T., Funaki J., Kitada M., Kamataki T. Molecular cloning of monkey liver cytochrome P-450 cDNAs: Similarity of the primary sequences to human cytochromes P-450. Biochim. Biophys. Acta 1992; 1171: 141–146
   PubMed Web of Science ®Google Scholar
• Nakura H., Itoh S., Kusano H., Ishizone H., Deguchi T., Kamataki T. Evidence for the lack of hepatic N-acetyltransferase in suncus (Suncus murinus). Biochem. Pharmacol. 1995; 50: 1165–1170
   PubMed Web of Science ®Google Scholar
• Yokoi T., Kosaka Y., Chiba M., Chiba K., Nakamura H., Ishizaki T., Kinishita M., Sato K., Gonzalez F. J. A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype. Pharmacogenetics 1996; 6: 395–401
   PubMedGoogle Scholar
• Nunoya K., Yokoi Y., Kimura K., Kodama T., Funayama M., Inoue K., Nagashima K., Funae Y., Shimada N., Green C., Kamataki T. (+)-Cis-3,5-dimethyl-2-(3-pyridyl)-thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes. J. Pharmacol. Exp. Ther. 1996; 277: 768–774
   PubMed Web of Science ®Google Scholar
• Yamamoto I., Watanabe K., Narimatsu S., Yoshimura H. Recent advances in the metabolism of cannabinoids. Int. J. Biochem. Cell Biol. 1995; 27: 741–746
   PubMed Web of Science ®Google Scholar
• Watanabe K., Yamamoto I., Oguri K., Yoshimura H. Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position. Eur. J. Pharmacol. 1980; 63: 1–6
   PubMed Web of Science ®Google Scholar
• Narimatsu S., Yamamoto I., Yoshimura H. Stereospecific hydrolysis of 8α, 9α- and 8β, 9β-epoxyhexahydrocannabinols in the mouse in vivo and in vitro. Xenobiotica 1985; 15: 227–235
   PubMed Web of Science ®Google Scholar
• Narimatsu S., Matsubara K., Shimonishi T., Watanabe K., Yamamoto I., Yoshimura H. Enzymatic oxidation of 7-hydroxylated delta 8-tetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol by hepatic microsomes of the guinea pig. Drug Metab. Dispos. 1988; 16: 156–161
   PubMed Web of Science ®Google Scholar
• Yamamoto I., Gohda H., Narimatsu S., Watanabe K., Yoshimura H. Cannabielsoin as a new metabolite of cannabidiol in mammals. Pharmacol. Biochem. Behav. 1991; 40: 541–546
   PubMed Web of Science ®Google Scholar
• Watanabe K., Narimatsu S., Yamamoto I., Yoshimura H. Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P-450 isozyme. J. Biol. Chem. 1991; 266: 2709–2711
   PubMed Web of Science ®Google Scholar
• Matsunaga T., Iwawaki Y., Watanabe K., Yamamoto I., Kageyama T., Yoshimura H. Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys. Life Sci. 1995; 56: 2089–2095
   PubMed Web of Science ®Google Scholar
• Matsunaga T., Watanabe K., Yamamoto I., Negishi M., Gonzalez F. J., Yoshimura H. cDNA cloning and sequence of CYP2C29 encoding P-450 MUT-2, a microsomal aldehyde oxygenase. Biochim. Biophys. Acta 1994; 1184: 299–301
   PubMed Web of Science ®Google Scholar
• Narimatsu S., Watanabe K., Yamamoto I., Yoshimura H. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver. Drug Metab. Dispos. 1988; 16: 880–889
   PubMed Web of Science ®Google Scholar
• Watanabe K., Kayano Y., Matsunaga T., Yamamoto I., Yoshimura H. Purification and characterization of a novel 46.5-kilodalton esterase from mouse hepatic microsomes. Biochem, Mol. Biol. Int. 1993; 31: 25–30
   PubMedGoogle Scholar
• Kotake A. N., Funae Y. High-performance liquid chromatography technique for resolving multiple forms of hepatic membrane-bound cytochrome P-450. Proc. Natl. Acad. Sci. USA 1980; 77: 6473–6475
   PubMed Web of Science ®Google Scholar
• Funae Y., Imaoka S. Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochim. Biophys. Acta 1985; 842: 119–132
   PubMed Web of Science ®Google Scholar
• Funae Y., Imaoka S. Cytochrome P450 in Rodents. Handbook of Experimental Pharmacology, J. B. Schenkman, R. Greim. Springer-Verlag, Heidelberg 1993; 105, 221–238
   Google Scholar
• Shimojo N., Ishizaki T., Imaoka S., Funae Y., Fujii S., Okuda K. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol. 1993; 46: 621–627
   PubMed Web of Science ®Google Scholar
• Imaoka S., Terano Y., Funae Y. Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. Arch. Biochem. Biophys. 1990; 278: 168–178
   PubMed Web of Science ®Google Scholar
• Imaoka S., Fujita S., Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochim. Biophys. Acta 1991; 1097: 187–192
   PubMed Web of Science ®Google Scholar
• Imaoka S., Yamada T., Hiroi T., Hayashi K., Sakaki T., Yabusaki Y., Funae Y. Multiple forms of human P450 expressed in Saccharomyces cerevisiae: Systematic characterization and comparison with those of the rat. Biochem. Pharmacol. 1996; 51: 1041–1050
   PubMed Web of Science ®Google Scholar
• Imaoka S., Hiroi T., Tamura Y., Yamazaki H., Shimada T., Komori M., Degawa M., Funae Y. Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: Cloning and characterization of mouse CYP4B1. Arch. Biochem. Biophys. 1995; 321: 255–262
   PubMed Web of Science ®Google Scholar
• Shimada T., Misono K. S., Guengerich F. P. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 1986; 261: 909–921
   PubMed Web of Science ®Google Scholar
• Shimada T., Guengerich F. P. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. USA 1989; 86: 462–465
   PubMed Web of Science ®Google Scholar
• Shimada T., Iwasaki M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res. 1989; 49: 3218–3228
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Inui Y., Wrighton S. A., Guengerich F. P., Shimada T. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis 1995; 16: 2167–2170
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Nakano M., Imai Y., Ueng Y. F., Guengerich F. P., Shimada T. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys. 1996; 325: 174–182
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Guo Z., Persmark M., Mimura M., Inoue K., Guengerich F. P., Shimada T. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol. Pharmacol. 1994; 46: 568–577
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Oda Y., Hiratsuka A., Watabe T., Guengerich F. T. Activation and inactivation of carcinogenic dehaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem. Res. Toxicol. 1996; 9: 333–340
   PubMed Web of Science ®Google Scholar
• Ishizaki T., Horai Y., Koya G., Matsuyama K., Iguchi S. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus. Arthritis Rheum. 1981; 24: 1245–1254
   PubMed Web of Science ®Google Scholar
• Horai Y., Fujita K., Ishizaki T. Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. Eur. J. Clin. Pharmacol. 1989; 37: 581–587
   PubMed Web of Science ®Google Scholar
• Tsujimoto G., Horai Y., Ishizaki T., Itoh K. Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient. Br. J. Clin. Pharmacol. 1981; 11: 622–625
   PubMed Web of Science ®Google Scholar
• Horai Y., Zhou H. H., Zhang L. M., Ishizaki T. N-Acetylation phenotyping with dapsone in a mainland Chinese population. Br. J. Clin. Pharmacol. 1988; 25: 81–87
   PubMed Web of Science ®Google Scholar
• Horai Y., Ishizaki T. N-Acetylation polymorphism of dapsone in a Japanese population. Br. J. Clin. Pharmacol. 1988; 25: 487–494
   PubMed Web of Science ®Google Scholar
• Setiabudy R., Kusaka M., Chiba K., Darmansjah I., Ishizaki T. Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: A cocktail and extended phenotyping assessment trial. Clin. Pharmacol. Ther. 1994; 56: 142–153
   PubMed Web of Science ®Google Scholar
• Horai Y., Nakano M., Ishizaki T., Ishikawa K., Zhou H. H., Zhou B. I., Liao C. L., Zhang L. M. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin. Pharmacol. Ther. 1989; 46: 198–207
   PubMed Web of Science ®Google Scholar
• Sohn D. R., Shin S. G. Ishizaki T. S-Mephenytoin pharmacogenetics and its clinical implications in Asian ethnic populations. Asian Pacific J. Pharmacol. 1994; 9: 287–301
   Web of Science ®Google Scholar
• Satoh T., Moroi K. Species and age differences in the study of isocarboxazid hydrolyzing enzyme. Arch. Int. Pharmacodyn. Ther. 1971; 192: 128
   PubMedGoogle Scholar
• Moroi K., Satoh T. Modification of procaine metabolism in rat liver after administration of phenobarbital or ethyl-p-nitrophenyl phenylphosphonothioate. Biochem. Pharmacol. 1975; 24: 1435
   Google Scholar
• Satoh T. Role of carboxylesterases in xenobiotic metabolism. Rev. Biochem. Toxicol. 1987; 8: 155–181
   Google Scholar
• Hosokawa M., Maki T., Satoh T. Multiplicity and regulation of hepatic microsomal carboxylesterases in rat. Mol. Pharmacol. 1987; 31: 579–584
   PubMed Web of Science ®Google Scholar
• Hosokawa M., Maki T., Satoh T. Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch. Biochem. Biophys. 1990; 277: 219–227
   PubMed Web of Science ®Google Scholar
• Satoh T., Hosokawa M. Molecular aspects of carboxylesterase isoforms in comparison with other esterases. Toxicol. Lett. 1995; 82/83: 439–445
   Web of Science ®Google Scholar
• *This paper was refereed by Dr. Ronald Estabrook W. University of Texas South-western Medical Center, Dallas, TX, and by Dr. James R. Gillette NIH, Bethesda, MD.
   Google Scholar